Envisagenics
Long Island City, United States · Founded 2014 · $27.4M raised
- Headquarters
- Long Island City, New York
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- envisagenics.com
- Total Funding
- $27.4M
- Last Round
- $25.0M Series BJun 2024
- Rounds
- 3
About
AI-driven biotechnology company discovering RNA splicing targets and developing therapeutics for oncology and neurodegeneration.
Summary
Envisagenics is an Artificial Intelligence company based in Long Island City, United States, founded in 2014. It has raised $27.4M in total across 3 rounds, most recently a $25.0M Series B round in Jun 2024. Investors include Third Kind Venture Capital, Red Cell Partners and Dynamk Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...